Radio-labeled
Showing 1 - 25 of 1,962
Colorectal Tumors, Colorectal Cancer, Colorectal Tumor Trial in New York (Iodine-124 labeled humanized A33 (antibody))
Active, not recruiting
- Colorectal Neoplasms
- +3 more
- Iodine-124 labeled humanized A33 (antibody)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 26, 2022
Healthy Trial in Madison (Radio-labeled rodatristat ethyl 600 mg)
Completed
- Healthy
- Radio-labeled rodatristat ethyl 600 mg
-
Madison, WisconsinCovance Clinical Research Unit
Jul 12, 2022
Liver Disease Chronic Trial in Stockholm (stable isotopes)
Not yet recruiting
- Liver Disease Chronic
- stable isotopes
-
Stockholm, SwedenKarolinska Institutet
Jul 23, 2023
Metastatic Colorectal Cancer Trial in Nantes (Antibody TF2, 90-Y-IMP-288, 111-In-IMP-288)
Terminated
- Metastatic Colorectal Cancer
- Antibody TF2
- +2 more
-
Nantes, FranceCHU de Nantes
Jul 29, 2022
Blood Safety Trial in Bergen (Mirasol treatment of whole blood)
Completed
- Blood Safety
- Mirasol treatment of whole blood
-
Bergen, NorwayHaukeland University Hospital
May 30, 2019
E-cigarette Use Trial in Columbus (C-11 labeled nicotine, PET/CT imaging)
Recruiting
- E-cigarette Use
- C-11 labeled nicotine
- PET/CT imaging
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Apr 15, 2022
Disintegration, Healthy Trial in Glasgow (EDP1815 capsule A, EDP1815 capsule B, EDP1815 tablet)
Active, not recruiting
- Disintegration
- Healthy
- EDP1815 capsule A
- +2 more
-
Glasgow, Scotland, United KingdomBDD Pharma Ltd
Jul 28, 2022
Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8 Trial in Duarte (Copper Cu
Recruiting
- Locally Advanced Rectal Carcinoma
- +4 more
- Copper Cu 64 Anti-CEA Monoclonal Antibody M5A
- Imaging Technique
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Absorption, Metabolism and Excretion in Healthy Volunteers Trial in Madison ([14C]-PBI-200)
Completed
- Absorption, Metabolism and Excretion in Healthy Volunteers
-
Madison, WisconsinLabcorp Clinical Research Unit Inc
Aug 24, 2022
Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)
Active, not recruiting
- Recurrent Adult Hodgkin Lymphoma
- basiliximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Atrial Fibrillation, Persistent, Atrial Fibrillation Recurrent Trial (Radio frequency ablation)
Not yet recruiting
- Atrial Fibrillation, Persistent
- Atrial Fibrillation Recurrent
- Radio frequency ablation
- (no location specified)
Oct 22, 2023
Pancreas Adenocarcinoma Trial in Leiden (Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101)
Not yet recruiting
- Pancreas Adenocarcinoma
- Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101
-
Leiden, NetherlandsLeiden University Medical Center
Aug 2, 2023
Healthy Trial (Dual isotope method)
Not yet recruiting
- Healthy
- Dual isotope method
- (no location specified)
Jun 21, 2022
11C-para-aminobenzoic Acid
Recruiting
- Renal Excretion
- +3 more
- 11C-para-aminobenzoic acid PET/CT
- Probenecid
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jan 30, 2023
Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial in London (PET Scan, [F-18]-DCFPyL Injection, Sodium MRI)
Recruiting
- Prostate Cancer
- +2 more
- PET Scan
- +3 more
-
London, Ontario, CanadaLondon Health Sciences Centre
Dec 6, 2021
Advanced Solid Tumors, Pharmacokinetics of 14C-OSI-906 Trial in Tacoma (radio-labeled OSI-906, OSI-906)
Completed
- Advanced Solid Tumors
- Pharmacokinetics of 14C-OSI-906
- radio-labeled OSI-906
- OSI-906
-
Tacoma, Washington
- +1 more
Feb 14, 2019
Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers
Recruiting
- Ocular Sebaceous Carcinoma
- +5 more
- Sentinel Lymph Node Biopsy
-
Roma, Rome, ItalyGustavo Savino
Apr 3, 2023
Solid Tumor Trial in Beijing (18F-DX600 PET/CT)
Recruiting
- Solid Tumor
- 18F-DX600 PET/CT
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jul 18, 2022
Solid Tumor Trial in Beijing (68Ga-DX600 PET/CT)
Completed
- Solid Tumor
- 68Ga-DX600 PET/CT
-
Beijing, Beijing, ChinaEthics Committee of Peking University Cancer Hospital
Jul 18, 2022
Gastrointestinal Tumors Trial in Beijing (68Ga-WL12 PET/CT)
Recruiting
- Gastrointestinal Tumors
- 68Ga-WL12 PET/CT
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jul 18, 2022
Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- DE-HyART
- +3 more
-
Delhi, IndiaRajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023
Leukemia Trial (90-Yttrium-labelled anti-CD66 mAb)
Not yet recruiting
- Leukemia
- 90-Yttrium-labelled anti-CD66 monoclonal antibody
- (no location specified)
Aug 16, 2022
Hepatocellular Carcinoma Trial in Rochester (Ga-68 labeled PSMA-11, Possible liver biopsy for locoregional therapy group)
Recruiting
- Hepatocellular Carcinoma
- Ga-68 labeled PSMA-11
- Possible liver biopsy for locoregional therapy group
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 18, 2022
Prostate Cancer, Advanced Prostate Carcinoma Trial in San Francisco (Hyperpolarized C13, Magnetic Resonance Imaging (MRI))
Recruiting
- Prostate Cancer
- Advanced Prostate Carcinoma
- Hyperpolarized C13
- Magnetic Resonance Imaging (MRI)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 27, 2022